Скачать или смотреть S1E1. Oncology at a crossroads: Clinical Trials, Regulation, Financing with Oliver Overheu, MD

Oncology is advancing fast, but trial design, regulation, and financing are under strain. Join Dr. Oliver and Dr. Julien as we discuss over morning coffee: shifting FDA standards, new funding realities, the battle of modalities, and what it all means for patients. We’ll close with where oncology innovation may head in the next decade.

We have covered:

— Trial Design in Flux: evolving endpoints, single-arm designs, impact on patients and sponsors
— Regulatory Shifts: FDA expectations, accelerated approval debates, pipeline implications
— The Money Question: pharma derisking, early-stage drought, hype-cycle dynamics
— Therapeutic Landscape in Motion: precision oncology, ADCs, CAR-T, bispecifics, radiopharma
— Patients at the Center: trial access, decentralized models, clinical reality
— Future Outlook: what the next 5-10 years could hold.

LinkedIn:   / julienwillard  
Julien's Website: https://julienwillard.com/